This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_RENAL_CELL_CARCINOMA_EXALLC for full statistics.
Renal cell carcinoma of kidney
C3_RENAL_CELL_CARCINOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1265 |
4. Check minimum number of eventsNone |
1265 |
5. Include endpointsNone |
1265 |
6. Filter based on genotype QC (FinnGen only) |
1265 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Renal cell carcinoma of kidney
based on the number of shared cases.
Similar with more cases:
- Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of kidney, except renal pelvis
- Malignant neoplasm of urinary organs
- Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1265 | 474 | 791 |
| Unadjusted period prevalence (%) | 0.28 | 0.16 | 0.35 |
| Median age at first event (years) | 63.23 | 60.73 | 64.72 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1178
- Matched controls
- 11774
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
80.0
323.0
574
138
KAC10
NOMESCO Finland
Total nephrectomy with capsule
243.8
323.0
413
26
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
172.2
323.0
334
27
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
687.5
323.0
1021
108
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
323.0
1013
*
8317/3-C64.9
ICD-O-3
Renal cell carcinoma, chromophobe type of kidney, NOS
+∞
161.2
151
*
7125
FHL
Nephrectomy (extrrafascial)
1580.2
146.0
139
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
70.3
129.7
148
24
197
Kela drug reimbursment
Sunitinib
141.3
109.2
115
9
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
1101.7
104.9
101
*
L01XE04
ATC
[U] sunitinib; oral
230.1
103.3
105
5
KAC00
NOMESCO Finland
Nephrectomy
80.5
98.2
110
15
130
Kela drug reimbursment
Malignant tumour
5.9
98.2
310
667
C64.80
ICD-10 Finland
Wilms tumour
126.5
97.7
104
9
KAD00
NOMESCO Finland
Partial nephrectomy
72.6
93.3
106
16
180
Kela drug reimbursment
Interferon alfa
73.6
83.8
95
14
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
54.9
69.2
82
16
JN4AD
NOMESCO Finland
Body CT examination
4.8
57.6
212
515
U75
ICPC
Malignant neoplasm of kidney
84.6
57.6
64
8
1890X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]
+∞
53.5
51
*
C648
ICD-10 Finland
NA
+∞
52.5
50
*
1502
Kela drug reimbursment
Cabozantinib
80.8
48.3
54
7
3012
Kela drug reimbursment
Cabozantinib
79.3
47.3
53
7
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
14.0
45.5
79
60
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
44.2
256
910
322
Kela drug reimbursment
Sunitinib
122.2
44.1
47
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
20.5
44.0
66
34
JN4BD
NOMESCO Finland
Extensive body CT
3.4
42.5
237
817
159
Kela drug reimbursment
Pazopanib
59.7
39.5
46
8
158
Kela drug reimbursment
Everolimus
201.4
38.0
39
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.0
35.1
118
255
L01XE26
ATC
[U] cabozantinib; oral
185.4
34.9
36
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.8
33.8
99
182
B01AB10
ATC
tinzaparin; parenteral
3.9
32.4
144
408
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.5
32.3
166
531
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
8.8
32.1
70
84
N02AX02
ATC
tramadol; systemic, rectal
2.1
31.6
585
3778
L01XE11
ATC
[U] pazopanib; oral
52.9
30.5
36
7
L03AA04
ATC
NA
49.9
28.5
34
7
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.7
27.4
71
111
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
13.1
27.3
48
38
18900
ICD-8 Finland
Malignant neoplasm of other and unspecified urinary organs, Kidney, except pelvis
+∞
26.1
25
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.8
24.3
70
126
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.7
24.0
110
319
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
34.1
23.4
30
9
L01EX07
ATC
cabozantinib; oral
45.9
22.4
27
6
L03AB05
ATC
interferon alfa-2b; parenteral
24.4
22.2
31
13
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
21.5
288
1569
KA3LT
NOMESCO Finland
Njurlesion coagulation
44.2
21.5
26
6
A11CC03
ATC
alfacalcidol; systemic
5.5
21.3
64
122
168
Kela drug reimbursment
Axitinib
112.0
20.6
22
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.0
20.1
82
215
L03AB04
ATC
interferon alfa-2a; parenteral
29.5
19.7
26
9
L01XE10
ATC
[U] everolimus; oral
106.8
19.6
21
*
198
Kela drug reimbursment
Sorafenib
34.9
18.9
24
7
A12AA04
ATC
calcium carbonate; oral
6.7
17.3
44
68
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
17.1
330
2040
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.1
16.7
53
108
340
Kela drug reimbursment
Everolimus
+∞
16.7
16
*
1890A
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]
+∞
16.7
16
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.8
16.7
72
199
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.9
16.5
104
380
TK800
NOMESCO Finland
Hemodialysis
5.3
16.2
49
95
B01AB05
ATC
enoxaparin; parenteral
1.7
15.7
392
2619
N18.8
ICD-10 Finland
Other chronic renal failure
3.7
15.6
68
190
Z49.0
ICD-10 Finland
Preparatory care for dialysis
8.9
15.3
32
37
N02AA05
ATC
oxycodone; systemic
1.9
15.2
235
1337
M04AA01
ATC
allopurinol; systemic
2.0
15.0
226
1269
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
8.4
14.8
32
39
L01XE17
ATC
[U] axitinib; oral
81.1
14.6
16
*
R31
ICD-10 Finland
Unspecified haematuria
2.1
14.5
188
995
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.6
14.3
49
109
U14
ICPC
Kidney symptom/complaint
6.1
13.8
37
62
L01XE05
ATC
[U] sorafenib; oral
28.7
13.0
17
6
343
Kela drug reimbursment
Pazopanib
50.6
12.9
15
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.2
12.7
47
114
205
Kela drug reimbursment
Chronic hypertension
1.6
12.5
441
3197
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
12.5
12
*
N18.0
ICD-10 Finland
End-stage renal disease
5.9
12.4
34
59
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
12.2
363
2514
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
11.2
12.0
22
20
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
11.8
155
822
C08CA01
ATC
amlodipine; oral
1.6
11.7
475
3553
361
Kela drug reimbursment
Axitinib
65.6
11.6
13
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
11.6
109
497
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.7
11.5
32
57
R50.9
ICD-10 Finland
Fever, unspecified
2.0
11.3
164
901
V03AE01
ATC
polystyrene sulfonate; oral
5.0
11.2
35
72
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
11.2
535
4142
137
Kela drug reimbursment
Uraemia requiring dialysis
8.1
11.1
24
30
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
10.9
140
732
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.5
10.9
85
352
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.9
10.6
43
114
L01EX01
ATC
sunitinib; oral
60.5
10.6
12
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
10.4
94
421
WZC30
NOMESCO Finland
Teaching
1.9
10.2
154
858
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
6.2
10.0
26
43
7124
FHL
Nephrectomy (simple
40.4
10.0
12
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
5.7
9.8
27
48
C03CA01
ATC
furosemide; systemic
1.5
9.8
458
3498
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
7.4
9.7
22
30
Z90.5
ICD-10 Finland
Acquired absence of kidney
55.4
9.7
11
*
UKC02
NOMESCO Finland
Cystoscopy
1.6
9.4
252
1683
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
21.9
9.4
13
6
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
5.8
9.2
25
44
V03AE02
ATC
sevelamer; oral
11.6
9.1
16
14
B02AA02
ATC
tranexamic acid; systemic
1.9
9.0
130
714
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
8.8
324
2329
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
5.7
8.8
24
43
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
50.3
8.7
10
*
B05DA
ATC
Isotonic solutions
8.3
8.6
18
22
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
7.0
8.6
20
29
BCA30
NOMESCO Finland
Unilateral adrenalectomy
27.7
8.5
11
*
SPAT1153
SPAT
Removal of sutures
1.5
8.4
362
2696
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
5.9
8.3
22
38
B03XA02
ATC
darbepoetin alfa; parenteral
3.6
8.3
35
98
RD211
NOMESCO Finland
NA
2.7
8.1
53
202
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
33.6
8.1
10
*
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
33.6
8.1
10
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.1
8.0
15
15
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
8.0
59
240
N02AA01
ATC
morphine; systemic, rectal
3.6
7.7
33
94
J01MA02
ATC
ciprofloxacin; systemic
1.4
7.7
457
3616
H02AB02
ATC
dexamethasone; systemic
1.9
7.6
115
644
KAC20
NOMESCO Finland
Nephroureterectomy
11.9
7.6
13
11
M907, C6488
ICD-10 Finland
NA
80.5
7.4
8
*
C02AC05
ATC
moxonidine; oral
2.2
7.4
71
329
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.3
7.3
63
277
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
6.9
7.3
17
25
Z51.5
ICD-10 Finland
Palliative care
2.0
7.3
91
475
Z31.5
ICD-10 Finland
Genetic counselling
3.1
7.1
37
123
TK820
NOMESCO Finland
Peritoneal dialysis
12.1
7.1
12
10
Z49.2
ICD-10 Finland
Other dialysis
6.7
6.8
16
24
GDA20
NOMESCO Finland
Excision of lesion of lung
40.3
6.8
8
*
JLC10
NOMESCO Finland
Distal pancreatectomy
16.8
6.7
10
6
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
16.8
6.7
10
6
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
16.8
6.7
10
6
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.5
6.7
50
205
B05DB
ATC
Hypertonic solutions
7.9
6.6
14
18
M05BA02
ATC
clodronic acid; systemic
5.9
6.6
17
29
E83.50
ICD-10 Finland
Hypercalcemia
4.4
6.5
22
51
2230A
ICD-9 Finland
Benign neoplasm of kidney and other urinary organs, Kidney, except pelvis
70.2
6.4
7
*
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
6.0
6.3
16
27
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
11.1
6.3
11
10
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
9.3
6.3
12
13
1891X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]
+∞
6.3
6
*
7121
FHL
Removal of local change or renal resection (eg cyst)
+∞
6.3
6
*
8318/3-C64.9
ICD-O-3
Renal cell carcinoma, sarcomatoid of kidney, NOS
+∞
6.3
6
*
8316/3-C64.9
ICD-O-3
Cyst-associated renal cell carcinoma of kidney, NOS
+∞
6.3
6
*
C08CA13
ATC
lercanidipine; oral
1.6
6.2
161
1054
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
26.8
6.2
8
*
B03XA01
ATC
erythropoietin; parenteral
4.5
6.2
20
45
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
12.6
6.1
10
8
C07AB02
ATC
metoprolol; systemic
1.4
6.1
288
2166
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
3.2
6.0
29
92
M05BX04
ATC
denosumab; parenteral
2.1
6.0
67
335
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
252
1015
2.85
43.62
9.7
6.6
12.0
11.1
mmol/l
0.98
238
959
302
1446
2.43
36.13
8.6
5.4
1.1
1.0
mmol/l
3.75
277
1324
185
813
2.49
26.06
5.5
3.8
133.2
100.4
ng/l
2.74
163
695
156
720
2.33
19.48
6.7
8.2
1.3
1.4
%
0.76
156
713
155
715
2.33
19.37
6.7
8.3
0.6
0.7
%
1.93
155
708
538
3879
1.67
17.12
4.6
3.5
—
—
—
0
0
153
757
2.16
16.05
3.9
3.1
49.4
58.6
ml/min/173m2
4.87
104
330
350
2337
1.69
14.40
3.2
2.7
2.9
4.5
e6/l
5.04
316
2073
226
1355
1.81
13.51
6.0
6.7
5.1
5.1
kpa
0.29
219
1284
226
1356
1.81
13.48
6.0
6.7
12.8
11.7
kpa
2.52
218
1287
584
4475
1.57
13.43
4.8
4.2
—
—
—
0
0
225
1359
1.80
13.10
6.0
6.7
0.2
1.2
mmol/l
3.24
175
1041
593
4585
1.55
12.94
7.3
4.8
34.0
34.5
g/l
1.10
558
4240
616
4804
1.55
12.92
10.4
5.9
1.2
1.2
mmol/l
1.39
580
4301
45
139
3.32
12.12
1.3
1.3
22.2
9.2
u/l
2.55
34
104
259
1673
1.69
11.79
4.3
3.2
0.8
0.8
mmol/l
0.55
247
1548
647
5255
1.47
10.25
12.6
6.8
1.2
1.2
mmol/l
0.53
556
4398
136
756
1.89
10.23
6.9
6.3
24.3
24.3
mmol/l
0.02
131
709
145
828
1.85
10.03
4.8
2.1
407.8
372.9
nmol/l
1.33
138
754
775
6553
1.47
9.78
6.2
5.0
497.3
2268.8
e6/l
1.22
18
130
62
259
2.47
9.66
2.8
2.9
1.9
1.8
mg/l
0.19
56
233
354
2573
1.52
9.58
6.4
4.4
0.0
0.0
estimate
0.50
112
822
11
11
10.08
9.55
1.9
1.5
136.9
102.5
ng/l
0.30
11
11
360
2641
1.51
9.28
4.0
2.8
3612.0
8031.9
umol/l
1.04
308
2223
205
1322
1.66
9.23
4.1
3.9
255.8
251.4
u/l
0.11
197
1245
292
2073
1.53
8.71
6.6
4.5
1.0
1.0
kg/l
0.08
40
309
394
2982
1.47
8.58
4.0
3.4
0.2
0.5
e6/l
6.73
335
2335
454
3538
1.44
8.44
6.0
4.4
—
—
—
0
0
234
1596
1.57
8.32
4.2
2.5
2.1
2.2
g/l
6.00
218
1463
560
4574
1.40
7.83
7.2
5.5
0.0
0.0
estimate
0.00
120
869
158
996
1.67
7.72
6.2
6.5
1.1
1.4
mmol/l
6.07
152
951
221
1512
1.56
7.72
4.4
2.5
19.9
22.1
%
1.93
188
1283
565
4638
1.39
7.59
6.0
4.1
0.0
0.0
estimate
0.50
124
852
246
1740
1.51
7.35
4.2
2.5
10.3
12.1
umol/l
4.27
228
1596
398
3096
1.42
7.24
3.8
2.5
64.7
57.0
u/l
1.04
374
2847
556
4580
1.38
7.19
5.8
4.1
0.0
0.0
estimate
0.00
122
869
627
5277
1.37
7.05
10.6
6.2
11.1
12.4
umol/l
0.85
601
4991
798
8891
0.72
6.92
6.0
5.0
6.1
6.1
mmol/l
0.19
721
7876
635
5366
1.37
6.91
12.7
8.8
4.3
4.3
e9/l
0.11
569
4649
131
814
1.68
6.76
1.8
1.7
—
—
—
0
0
320
2438
1.42
6.43
2.9
2.4
—
—
—
0
0
186
1278
1.53
6.32
14.8
8.8
—
—
—
0
0
843
7503
1.37
6.32
13.3
7.6
80.9
81.2
u/l
0.07
805
6977
78
428
1.88
6.15
4.3
3.3
4.2
4.4
pmol/l
0.40
67
368
160
1085
1.54
5.76
6.5
3.5
0.8
2.1
mmol/l
4.34
122
851
436
3564
1.34
5.54
5.7
3.4
2.4
2.3
mmol/l
2.16
386
3052
700
7842
0.76
5.41
25.1
19.0
37.8
38.6
%
0.99
412
4873
393
3173
1.35
5.39
3.8
3.1
6.9
7.3
mmol/l
0.84
327
2595
822
8993
0.75
5.22
5.5
5.3
2.5
2.6
mmol/l
0.96
741
8049
67
370
1.86
5.22
1.2
1.3
—
—
—
0
0
158
1093
1.51
5.19
6.1
3.5
5.7
5.8
kpa
0.52
153
1057
679
5968
1.30
4.91
6.2
4.8
7.0
6.9
mmol/l
0.54
653
5625
244
1853
1.39
4.87
3.3
2.9
0.7
1.1
e6/l
1.76
157
1111
920
9879
0.75
4.86
39.6
25.6
130.0
132.9
g/l
5.93
903
9658
86
530
1.67
4.63
8.5
3.7
23.0
24.2
mmol/l
3.84
73
479
106
689
1.59
4.61
5.5
3.7
0.8
2.0
mmol/l
2.30
74
519
401
3308
1.31
4.61
4.7
3.9
25.9
9.3
mg/mmol
3.72
274
2104
801
8743
0.77
4.60
5.1
4.7
4.4
4.4
mmol/l
0.62
727
7893
20
70
2.89
4.50
1.3
1.4
—
—
—
0
0
20
71
2.85
4.40
1.3
1.4
—
—
—
0
0
70
415
1.73
4.35
1.3
1.2
126.0
153.3
iu/ml
0.28
19
151
795
8651
0.78
4.21
5.0
4.6
1.4
1.4
mmol/l
4.93
719
7729
9
13
6.96
4.16
10.2
9.8
4.8
6.6
mmol/l
—
9
13
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
70
422
1.70
4.11
2.3
2.5
0.4
0.4
u/ml
0.07
37
247
94
612
1.58
4.08
7.6
8.7
23.1
24.4
mmol/l
4.54
87
565
16
53
3.04
3.97
1.4
1.4
—
—
—
0
0
16
53
3.04
3.97
1.4
1.4
—
—
—
0
0
37
184
2.04
3.96
4.4
5.4
85.0
355.8
iu/ml
—
5
25
26
117
2.25
3.59
1.4
1.3
57.9
29.5
iu/l
2.50
18
101
796
8586
0.80
3.43
7.7
6.4
41.8
41.0
mmol/mol
1.46
732
7783
25
116
2.18
3.23
2.4
1.3
0.6
0.6
nmol/l
0.08
25
108
160
1216
1.36
3.17
2.6
4.0
7.3
21.7
ug/l
1.26
130
1026
436
3803
1.22
2.87
2.6
2.2
81.2
78.4
nmol/l
1.15
393
3292
903
9550
0.81
2.87
16.5
11.1
30.1
25.1
u/l
0.45
865
9125
780
8367
0.82
2.84
4.6
4.2
1.5
1.3
mmol/l
9.17
699
7418
143
1088
1.35
2.82
3.0
2.5
4.2
6.5
ug/l
3.02
124
931
671
7298
0.83
2.81
29.3
21.2
14.2
14.0
%
3.57
652
7112
6
10
6.02
2.70
1.8
5.1
—
—
—
0
0
79
546
1.48
2.69
3.9
2.4
0.6
0.6
%
0.03
79
529
209
1692
1.28
2.66
2.1
2.0
30.4
30.0
s
0.39
209
1634
16
67
2.41
2.63
8.8
5.3
59.8
26.8
u/ml
—
5
23
231
1896
1.27
2.63
1.8
1.9
—
—
—
0
0
33
185
1.80
2.58
1.3
1.7
—
—
—
0
0
23
115
2.02
2.51
5.6
2.8
—
—
—
0
0
36
211
1.73
2.44
1.7
1.4
—
—
—
0
0
918
9645
0.82
2.42
32.5
20.9
4.1
4.0
mmol/l
24.54
891
9350
87
631
1.41
2.33
3.9
2.8
0.2
0.3
e6/l
0.33
87
616
253
2129
1.24
2.31
5.4
3.2
2.5
2.5
mmol/l
4.87
225
1857
198
2393
0.80
2.30
1.7
1.6
1.6
1.3
mmol/l
2.64
167
1965
918
9627
0.83
2.26
32.4
20.7
139.1
139.6
mmol/l
5.17
893
9345
42
264
1.61
2.22
1.2
1.2
—
—
—
0
0
5
9
5.57
2.21
1.0
1.3
—
—
—
0
0
212
1758
1.25
2.21
3.7
3.1
2.1
1.9
e6/l
0.13
126
1024
13
54
2.42
2.20
2.0
2.1
—
—
—
0
0
40
253
1.60
2.08
1.3
1.6
—
—
—
0
0
76
553
1.40
2.03
5.4
3.8
52.6
47.1
%
1.07
76
545
43
281
1.55
1.97
1.4
1.4
238.6
277.0
ug/g
0.59
25
169
42
273
1.56
1.97
2.5
2.4
242.7
81.4
ug/min
1.19
28
164
164
1340
1.26
1.95
1.7
1.8
—
—
—
0
0
28
165
1.71
1.92
1.6
1.5
3.0
5.7
iu/l
—
10
48
41
267
1.55
1.91
1.2
1.2
—
—
—
0
0
38
244
1.57
1.88
1.3
1.6
—
—
—
0
0
17
86
1.99
1.85
1.2
1.7
—
—
—
0
0
17
86
1.99
1.85
1.2
1.7
—
—
—
0
0
17
86
1.99
1.85
1.2
1.7
—
—
—
0
0
807
8498
0.86
1.81
25.7
16.6
59.6
72.9
ml/min/173m2
49.85
724
7058
37
239
1.56
1.80
3.5
2.3
127.9
127.9
g/l
0.00
27
180
776
8194
0.86
1.80
7.1
4.6
2.1
2.2
mu/l
0.24
711
7269
230
1967
1.21
1.79
1.6
1.7
1.3
1.4
mg/l
0.32
175
1553
6
18
3.34
1.74
2.7
2.8
502.7
4611.3
u/l
—
6
18
218
2535
0.83
1.73
3.2
3.3
0.9
0.8
ug/l
0.20
167
1784
17
89
1.92
1.70
1.1
1.2
—
—
u/ml
—
0
0
124
999
1.27
1.69
2.8
2.9
65.7
66.0
g/l
0.13
115
904
58
418
1.41
1.68
2.0
1.8
—
—
—
0
0
90
696
1.32
1.67
1.6
1.5
—
—
—
0
0
23
134
1.73
1.66
2.7
2.6
13.0
23.1
mg/l
—
6
37
12
56
2.15
1.61
2.2
1.6
1.2
3.7
u/field
—
5
37
36
238
1.53
1.61
1.3
1.2
—
—
—
0
0
18
99
1.83
1.57
1.4
1.8
—
—
—
0
0
25
152
1.66
1.57
1.3
1.5
—
—
—
0
0
160
1343
1.22
1.52
1.7
1.8
—
—
—
0
0
5
15
3.34
1.52
1.2
1.3
—
—
—
0
0
29
185
1.58
1.52
1.4
1.4
2125.1
1458.5
e6/l
0.31
24
135
75
575
1.32
1.50
1.7
1.8
1.8
1.6
g/l
1.33
62
495
21
124
1.70
1.47
2.0
1.5
—
—
—
0
0
58
430
1.37
1.45
2.5
3.2
45202.6
3454.6
u/ml
0.46
50
360
56
413
1.37
1.45
2.7
2.8
—
—
—
0
0
21
125
1.69
1.44
2.0
1.5
—
—
—
0
0
410
4472
0.88
1.41
2.1
2.1
94.0
92.2
pmol/l
0.33
217
2331
21
126
1.68
1.40
2.0
1.5
—
—
—
0
0
21
126
1.68
1.40
2.0
1.5
—
—
—
0
0
21
126
1.68
1.40
2.0
1.5
—
—
—
0
0
22
134
1.65
1.39
1.3
1.4
112.8
143.5
u/ml
—
6
21
22
134
1.65
1.39
1.3
1.5
—
—
—
0
0
17
96
1.78
1.39
1.3
1.3
—
—
—
0
0
35
239
1.48
1.38
3.9
2.5
16.9
15.6
%
1.37
21
121
21
127
1.66
1.37
2.0
1.5
—
—
—
0
0
6
23
2.62
1.37
1.2
1.1
4280.8
18.0
u/l
—
6
16
28
414
0.67
1.31
2.4
1.8
—
—
—
0
0
350
3176
1.14
1.30
2.2
2.2
147.2
239.0
u/l
2.15
328
2957
8
35
2.29
1.27
1.0
1.0
—
—
—
0
0
56
424
1.34
1.26
1.3
1.2
119.3
191.4
u/ml
1.19
45
381
728
6918
1.12
1.25
5.1
4.1
18.4
14.5
mm/h
5.12
668
6281
22
139
1.59
1.23
1.2
1.5
—
—
—
0
0
141
1649
0.84
1.21
1.2
1.2
0.7
1.7
u/ml
2.33
35
400
417
3842
1.13
1.21
3.7
2.8
233.8
159.5
ug/l
3.63
373
3445
18
109
1.66
1.19
1.7
1.4
—
—
—
0
0
24
157
1.54
1.17
1.1
1.2
—
—
—
0
0
16
94
1.71
1.17
1.4
1.6
—
—
—
0
0
26
174
1.50
1.15
1.3
1.5
—
—
—
0
0
135
1149
1.20
1.15
3.8
3.7
—
—
—
0
0
46
344
1.35
1.14
1.2
1.3
—
—
—
0
0
16
95
1.69
1.14
1.5
1.8
—
—
—
0
0
54
414
1.32
1.13
2.4
3.6
65.7
70.8
mg/l
0.11
46
340
54
414
1.32
1.13
2.4
3.6
50.4
74.2
mg/l
0.36
46
344
107
892
1.22
1.13
7.5
3.8
1.2
1.2
mmol/l
0.30
99
763
23
152
1.52
1.09
1.3
1.5
—
—
—
0
0
12
66
1.83
1.09
1.7
3.7
—
—
—
0
0
58
453
1.29
1.08
2.1
1.9
—
—
—
0
0
117
992
1.20
1.05
2.2
2.1
0.2
0.2
g/l
2.02
105
921
327
3559
0.89
1.05
4.8
4.7
23.1
21.7
%
0.85
184
1851
311
2846
1.12
1.00
2.4
2.2
3.6
3.2
mg/l
2.26
263
2396
5
110
0.45
1.00
1.2
1.0
—
—
—
0
0
24
164
1.47
0.99
1.4
1.4
184771.5
72260.6
e6/l
0.37
17
100
415
4445
0.90
0.99
5.3
5.4
5.7
4.5
ug/l
0.26
369
3905
22
319
0.68
0.98
1.1
1.0
—
—
—
0
0
0
29
0.00
0.97
0.0
1.2
—
—
—
0
0
19
124
1.54
0.97
1.3
1.6
—
—
—
0
0
11
62
1.78
0.94
1.3
1.3
—
—
—
0
0
16
101
1.59
0.93
3.9
2.2
0.6
2.0
u/field
—
5
31
21
144
1.47
0.87
1.8
2.4
—
1598.8
—
0
14
65
789
0.81
0.87
1.7
1.8
1.5
1.6
%
0.66
55
649
9
58
1.56
0.70
1.3
1.6
—
—
—
0
0
10
61
1.64
0.68
3.6
4.0
—
—
—
0
0
5
27
1.85
0.68
1.0
1.0
909.2
1728.4
miu/ml
—
5
27
311
2915
1.09
0.64
3.7
3.2
34.7
35.3
u/l
0.07
295
2770
8
51
1.57
0.60
1.3
1.2
—
—
—
0
0
442
4214
1.07
0.59
5.1
4.2
56.6
55.2
ng/l
0.03
368
3264
21
157
1.34
0.59
1.3
1.1
—
—
—
0
0
39
318
1.23
0.58
2.1
1.6
—
—
—
0
0
198
2138
0.91
0.56
4.7
4.1
258.8
325.2
ng/l
0.29
169
1838
6
37
1.62
0.55
1.0
1.2
—
—
—
0
0
66
757
0.86
0.53
1.3
1.3
—
—
—
0
0
380
3619
1.07
0.52
3.6
3.2
2868.6
1903.5
ng/l
1.97
343
3145
51
434
1.18
0.52
1.9
2.7
3.4
3.2
g/l
0.55
37
335
221
2364
0.92
0.52
1.7
1.8
1369.4
1174.0
nmol/l
1.85
164
1766
11
157
0.70
0.51
1.4
1.1
—
—
—
0
0
7
45
1.56
0.49
1.0
1.0
—
—
—
0
0
38
317
1.20
0.48
1.6
1.6
—
—
—
0
0
13
93
1.40
0.48
1.3
1.3
—
—
—
0
0
31
254
1.23
0.47
4.4
3.6
24.3
28.6
mg/l
0.24
15
171
25
200
1.25
0.46
2.0
1.2
57.7
46.5
u/l
0.12
18
174
16
120
1.34
0.46
1.4
1.6
—
—
—
0
0
7
49
1.43
0.46
1.3
1.9
—
—
—
0
0
7
49
1.43
0.46
1.3
1.9
—
—
—
0
0
7
49
1.43
0.46
1.3
1.9
—
—
—
0
0
7
49
1.43
0.46
1.3
1.9
—
—
—
0
0
101
917
1.11
0.43
2.6
2.3
165.5
32.7
u/l
0.51
88
768
896
9113
0.94
0.43
25.2
17.4
32.2
27.8
mg/l
2.74
797
7487
8
57
1.41
0.42
1.5
2.3
—
—
—
0
0
8
58
1.38
0.41
1.4
1.6
—
—
—
0
0
0
17
0.00
0.40
0.0
2.7
—
—
—
0
0
46
399
1.16
0.40
1.9
2.9
1.5
1.5
g/l
0.01
41
341
123
1134
1.09
0.40
3.1
2.7
9.8
10.1
umol/l
0.04
107
989
0
18
0.00
0.40
0.0
2.6
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
87.0
—
0
13
0
18
0.00
0.40
0.0
1.8
—
89.8
—
0
13
14
182
0.77
0.39
1.0
1.2
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
7
106
0.66
0.39
1.0
1.1
—
43.9
—
0
20
0
19
0.00
0.39
0.0
1.6
—
1.2
—
0
19
9
122
0.74
0.35
2.7
3.5
—
—
—
0
0
31
264
1.18
0.35
1.2
1.4
—
—
—
0
0
27
319
0.84
0.34
3.0
3.2
0.8
0.9
nmol/l
0.57
19
246
262
2736
0.95
0.33
1.7
1.6
19.2
20.2
nmol/l
0.47
232
2307
53
473
1.13
0.33
1.9
2.6
3.8
3.8
g/l
0.04
36
328
151
1420
1.07
0.32
2.8
2.4
1.7
1.8
%
0.33
136
1259
53
474
1.12
0.32
1.9
2.6
—
—
—
0
0
53
474
1.12
0.32
1.9
2.6
7.5
7.5
g/l
0.06
37
340
11
83
1.33
0.32
1.3
1.7
—
—
—
0
0
24
284
0.84
0.32
3.6
3.3
1.9
1.6
mmol/l
0.53
24
277
137
1285
1.07
0.32
1.2
1.2
13.6
14.2
u/ml
0.04
61
445
7
52
1.35
0.31
2.9
1.2
—
—
—
0
0
7
52
1.35
0.31
2.9
1.2
—
—
—
0
0
7
96
0.73
0.31
1.1
1.1
—
—
—
0
0
18
147
1.23
0.30
2.0
1.9
89.5
89.6
%
0.02
18
147
100
1074
0.92
0.29
3.1
3.1
348.2
254.9
ng/l
0.86
93
985
23
269
0.85
0.28
3.7
3.4
7.5
7.8
mmol/l
0.16
23
263
8
64
1.25
0.27
1.1
1.1
—
—
—
0
0
5
72
0.69
0.26
1.4
1.0
—
—
—
0
0
26
225
1.16
0.26
2.2
1.6
—
—
—
0
0
30
263
1.14
0.25
1.4
1.4
—
—
—
0
0
30
263
1.14
0.25
1.4
1.4
—
—
—
0
0
5
38
1.32
0.23
1.4
2.1
—
—
—
0
0
5
38
1.32
0.23
1.4
2.1
—
—
—
0
0
13
106
1.23
0.23
1.4
1.4
—
—
—
0
0
5
39
1.28
0.23
1.2
1.1
—
—
—
0
0
5
39
1.28
0.23
1.4
2.1
—
—
—
0
0
5
39
1.28
0.23
1.4
1.0
—
—
—
0
0
25
219
1.14
0.22
1.4
1.6
—
—
—
0
0
5
41
1.22
0.22
1.6
1.3
30.8
27.6
%
—
5
29
75
701
1.07
0.21
2.5
2.2
11.8
12.2
nmol/l
0.10
64
608
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
49
1.23
0.20
1.0
1.2
177.7
407.4
u/l
—
6
44
6
51
1.18
0.19
1.3
1.8
18.2
16.5
nmol/l
—
6
45
53
491
1.08
0.19
4.8
4.7
1.6
1.7
%
0.47
48
463
6
52
1.15
0.19
1.7
2.1
—
—
—
0
0
78
735
1.06
0.19
1.8
1.7
—
—
—
0
0
17
147
1.16
0.18
1.0
1.1
—
—
—
0
0
8
70
1.14
0.16
1.4
1.5
—
—
—
0
0
14
162
0.86
0.16
1.1
1.1
—
—
—
0
0
23
255
0.90
0.15
1.3
1.9
—
—
—
0
0
31
285
1.09
0.14
1.5
1.6
—
—
—
0
0
10
84
1.19
0.14
1.2
2.3
—
—
—
0
0
436
4293
1.02
0.14
2.4
2.4
—
—
—
0
0
47
441
1.07
0.13
2.0
2.7
10.2
10.7
g/l
0.29
38
371
30
277
1.08
0.12
1.2
1.4
—
—
—
0
0
28
259
1.08
0.11
1.3
1.5
—
—
—
0
0
173
1688
1.03
0.11
30.4
29.3
1.6
1.4
inr
0.64
19
216
10
86
1.16
0.11
1.0
1.1
—
—
—
0
0
539
5444
0.98
0.10
3.4
3.2
55.6
55.7
u/l
0.00
484
4942
242
2378
1.02
0.09
1.7
1.8
443.1
11948479.1
pmol/l
1.30
202
1925
119
1220
0.97
0.09
4.8
4.7
31.2
32.4
%
0.61
83
776
38
361
1.05
0.08
1.6
1.9
33.9
38.1
u/l
0.63
33
313
5
60
0.83
0.08
1.2
1.1
—
—
—
0
0
5
60
0.83
0.08
1.2
1.1
—
—
—
0
0
5
60
0.83
0.08
1.2
1.1
—
—
—
0
0
6
71
0.84
0.07
1.0
1.0
—
—
—
0
0
6
72
0.83
0.07
1.0
1.2
—
—
—
0
0
661
6649
0.99
0.07
6.4
3.7
15.4
15.1
pmol/l
3.04
612
5870
27
256
1.06
0.06
1.7
1.6
0.3
21.9
iu/ml
—
9
55
133
1350
0.98
0.05
1.3
1.3
19.4
38.5
iu/ml
3.56
39
419
20
191
1.05
0.03
4.0
3.1
59.0
60.0
%
0.11
20
191
18
188
0.96
0.02
1.5
1.6
—
—
—
0
0
16
153
1.05
0.01
1.1
1.4
—
—
—
0
0
16
156
1.03
0.00
1.4
1.3
—
—
—
0
0
37
366
1.01
0.00
2.0
2.7
34.8
36.8
g/l
0.96
32
310
25
249
1.00
0.00
1.5
3.0
25.6
35.4
umol/l
4.21
17
199
19
187
1.02
0.00
1.4
1.3
—
—
—
0
0
91
905
1.01
0.00
1.3
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
39.4
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
65
0.92
0.00
1.8
1.6
18.2
14.8
umol/l
—
6
60
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
21.6
—
0
5
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
2.6
—
0
5
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
5
55
0.91
0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
7
71
0.99
0.00
1.0
2.4
—
—
—
0
0
6
67
0.89
0.00
1.5
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
93.3
—
0
9
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RENAL_CELL_CARCINOMA – Renal cell carcinoma of kidney
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).